EUROSPINE 2017

FzioMed, Inc.


Website www.fziomed.com
Hall Liffey Exhibition Hall
Booth L77
Show on Map
Company Information

231 Bonetti Drive
San Luis Obispo, CA 93401
USA

Contact:
Email: tfanning@fziomed.com
Phone: 512-779-4142

FzioMed develops and commercializes absorbable surgical biomaterials based on its patented polymer science, for use in many surgical applications including spine, orthopedics, tendon, peripheral nerve, gynecology and general surgery.

  • Oxiplex® spine gel helps reduce adhesion formation and related symptoms such as pain. CE marked and approved in over 70 countries.
  • Dynavisc® adhesion barrier gel for tendon and peripheral nerve surgeries is CE marked and available in Europe, Australia and selected countries in the Middle East and Asia.
  • Oxiplex/AP®, an effective adhesion barrier for peritoneal surgery and intrauterine applications helps reduce the incidence, extent, and severity of postoperative adhesions. CE marked and available in Europe, Australia and selected countries in the Middle East and Asia. Intrauterine application requires approval in Australia and some Middle East and Asia countries. As of 30 May 2017, it is not approved in these countries for IU application.